https://www.gsk.com/en-gb/media/press-releases/gsk-receives-world-health-organization-prequalification-for-synflorix-pneumococcal-vaccine-four-dose-vial/
WHO awarded prequalification for the new four-dose vial presentation of Synflorix pneumococcal vaccine targeting GAVI supported countries.
world health organizationpneumococcal vaccinegskreceivessynflorix
https://pubmed.ncbi.nlm.nih.gov/37160867/
Pneumococcal conjugate vaccines (PCVs) protect against invasive pneumococcal disease (IPD) among vaccinees. However, at population level, this protection is...
the impactintroductionvalentpneumococcalconjugate
https://www.gavi.org/news/document-library/pneumococcal-vaccine-roadmap-public-summary
Gavi has supported routine introductions with pneumococcal vaccine since 2009. Find out more about the pneumococcal vaccine market, and Gavi’s approach to...
pneumococcal vaccinethe allianceroadmappublicsummary
https://www.biopharmadive.com/news/merck-pneumococcal-vaccine-fda-approval-capvaxive/719227/
The new vaccine, which Merck will sell as Capvaxive, will compete with Pfizer’s blockbuster Prevnar franchise.
merckwinsfdaokvaccine